// App-Quantinova.ai

212 : BPM 31510 synergizes gemcitabine efficacy in pancreatic adenocarcinoma via mechanism independent of its anti-Warburg influence on metabolism

Researchers

Presenter

  • Tulin Dadali

Principal Investigators

  • Anne R. Diers

  • Rakib Ouro-Djobo

  • Justin Bourdelais

  • Ezer Benaim

  • Bianca Jambhekar

  • Tony E. Walshe

  • Vivek K. Vishnudas

  • Joaquin J. Jimenez

  • Rangaprasad Sarangarajan

  • Niven R. Narain

Medical Centers

  • Berg LLC, Framingham, MA

  • University of Miami Miller School of Medicine, Miami, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Pancreatic cancer

  • Solid malignancies

  • Pancreatic and cerebellar agenesis

Biomarkers

  • N/A

Drug/Treatment

  • Gemcitabine

  • Ubidecarenone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved